ResearcherUniversity of IndonesiaNo recent work listed
Dadang Makmun
Matched on ORCID iD 0000-0002-9055-8678; OpenAlex author ID A5075479944. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2021: 1 paper · 2022: none · 2023: 1 paper
Papers 2
- The Expressions of NF-κB, COX-2, Sp1, and c-Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival. Last author DOI 10.3390/pathophysiology30020009↗
- Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. Last author DOI 10.5152/tjg.2021.211106↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kaka Renaldi · 2 shared papers, 2021–2023 · strength 0.30
- Paper Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review a… DOI 10.5152/tjg.2021.211106↗
- Paper The Expressions of NF-κB, COX-2, Sp1, and c-Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient… DOI 10.3390/pathophysiology30020009↗
- Andy William · 2 shared papers, 2021–2023 · strength 0.30
- Paper Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review a… DOI 10.5152/tjg.2021.211106↗
- Paper The Expressions of NF-κB, COX-2, Sp1, and c-Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient… DOI 10.3390/pathophysiology30020009↗
- Marcellus Simadibrata K · 2 shared papers, 2021–2023 · strength 0.30
- Paper Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review a… DOI 10.5152/tjg.2021.211106↗
- Paper The Expressions of NF-κB, COX-2, Sp1, and c-Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient… DOI 10.3390/pathophysiology30020009↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.